Clinical Trial Update: Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract [Phase 2]

View source ↗

Summary

Phase 2 trial update for presatovir in hematopoietic cell transplant recipients with respiratory syncytial virus infection of the upper respiratory tract; study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus

Drugs mentioned

• Presatovir (GS-5806)

Snippet

Sponsor: Gilead Sciences | Conditions: Respiratory Syncytial Virus | Phase 2 | Status: COMPLETED | Results posted: 2018-08-06